Detection of HTLV-1 proviral DNA in BM mononuclear cells and cultured mesenchymal stromal cells isolated from patients with HTLV-1 infection.

The bone marrow (BM) biology during HTLV-1 infection is obscure. In this study, we investigated BM mononuclear cells and mesenchymal stromal cells (MSC) from HTLV-1 asymptomatic and symptomatic individuals. An infiltration of CD4+ T-cell lymphocytes in the BM of HTLV-1-infected individuals was observed when compared to healthy controls. The provirus detection in the BM CD4+ T cells confirmed the presence of integrated HTLV DNA. In regard to MSC, we observed that the number of fibroblast progenitor cells was lower in HTLV-1 infected individuals than in healthy controls. Isolated HTLV-1 infected BM-MSC demonstrated surface expression markers and in vitro differentiation potential similar to uninfected individuals. The presence of HTLV-1 proviral DNA in the BM-MSC of HTLV-1-infected patients was demonstrated but no p19 antigen was detected in supernatant from cultured MSC. We suppose that HTLV-1 infects human MSC probably by cell-to-cell contact from the infected CD4+ T-lymphocytes infiltrated into the bone marrow.

• Publication year

  2018

• Venue

  Virology

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2018.04.014PMID 29723784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo

  2017cited by this paper
• Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma.

  2016cited by this paper
• Evaluation of human T-lymphotropic virus prevalence/co-infection rates for a four-year period in a non-metropolitan blood center in Southeast Brazil.

  2016cited by this paper
• HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics.

  2014cited by this paper
• Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.

  2013cited by this paper
• Potential Contribution of a Novel Tax Epitope–Specific CD4+ T Cells to Graft-versus-Tax Effect in Adult T Cell Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

  2013cited by this paper
• Bone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury.

  2013cited by this paper
• HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up.

  2012cited by this paper
• Epidemiological Aspects and World Distribution of HTLV-1 Infection

  2012cited by this paper
• Cytomegalovirus infection in mesenchymal stem cells and their activation could be enhanced by nuclear factor-κB inhibitor pyrrolidinedithiocarbamate in vitro.

  2011cited by this paper
• Bone and the hematopoietic niche: a tale of two stem cells.

  2011cited by this paper
• HIV Type 1 Alters Mesenchymal Stem Cell Differentiation Potential and Cell Phenotype ex Vivo

  2011cited by this paper
• Herpes Simplex Virus Type-1 (HSV-1) Entry into Human Mesenchymal Stem Cells Is Heavily Dependent on Heparan Sulfate

  2011cited by this paper
• HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells

  2011cited by this paper
• Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

  2010cited by this paper
• T‐lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow

  2009cited by this paper
• Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.

  2009cited by this paper
• A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.

  2008cited by this paper
• Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation.

  2008cited by this paper
• Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation

  2008cited by this paper
• Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.

  2007cited by this paper
• Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis

  2007cited by this paper
• Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

  2007cited by this paper
• HIV Proteins Regulate Bone Marker Secretion and Transcription Factor Activity in Cultured Human Osteoblasts with Consequent Potential Implications for Osteoblast Function and Development

  2007cited by this paper
• Anti‐HTLV‐1 tax antibody and tax‐specific cytotoxic T lymphocyte are associated with a reduction in HTLV‐1 proviral load in asymptomatic carriers

  2007cited by this paper
• Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual

  2006cited by this paper
• Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.

  2003cited by this paper
• Suppression of Clonogenic Potential of Human Bone Marrow Mesenchymal Stem Cells by HIV Type 1: Putative Role of HIV Type 1 Tat Protein and Inflammatory Cytokines

  2002cited by this paper
• Allogeneic bone marrow transplantation-related transmission of human T lymphotropic virus type I (HTLV-I)

  2000cited by this paper
• Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation.

  1998cited by this paper
• Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.

  1997cited by this paper
• Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease.

  1997cited by this paper
• In vivo infection of human T-cell leukemia virus type I in non-T cells.

  1993cited by this paper
• Abnormal in vitro proliferation and differentiation of T cell colony- forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers

  1993cited by this paper
• Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1.

  1993cited by this paper
• Lymphocyte-facilitated infection of epithelia by human T-cell lymphotropic virus type I

  1992cited by this paper
• Dendritic Cells from Patients with Tropical Spastic Paraparesis Are Infected with HTLV-1 and Stimulate Autologous Lymphocyte Proliferation

  1992cited by this paper
• In vivo cellular tropism of human T-cell leukemia virus type 1

  1990cited by this paper
• Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV‐I‐associated myelopathy

  1988cited by this paper
• Fibroblast precursors in normal and irradiated mouse hematopoietic organs.

  1976cited by this paper

• No citing papers are available for this paper.